186 related articles for article (PubMed ID: 11964084)
21. Isolation and characterization of human breast adenocarcinoma cells made resistant to alpha-difluoromethylornithine.
Das B; Vig M; Khurana KK; Madhubala R
Cancer Invest; 2000; 18(2):115-22. PubMed ID: 10705873
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of human ornithine decarboxylase activity by enantiomers of difluoromethylornithine.
Qu N; Ignatenko NA; Yamauchi P; Stringer DE; Levenson C; Shannon P; Perrin S; Gerner EW
Biochem J; 2003 Oct; 375(Pt 2):465-70. PubMed ID: 12859253
[TBL] [Abstract][Full Text] [Related]
23. [Antitumor effect of alpha-difluoromethylornithine (DFMO) changes in ornithine decarboxylase (ODC) activity and polyamine (PA) levels in human tumor transplanted into nude mice].
Umemoto S
Nihon Geka Gakkai Zasshi; 1989 May; 90(5):650-60. PubMed ID: 2507897
[TBL] [Abstract][Full Text] [Related]
24. Role of polyamines in the growth of hormone-responsive and -resistant human breast cancer cells in nude mice.
Manni A; Badger B; Martel J; Demers L
Cancer Lett; 1992 Sep; 66(1):1-9. PubMed ID: 1451091
[TBL] [Abstract][Full Text] [Related]
25. Individual and combined effects of alpha-difluoromethylornithine and ovariectomy on the growth and polyamine milieu of experimental breast cancer in rats.
Manni A; Badger B; Glikman P; Bartholomew M; Santner S; Demers L
Cancer Res; 1989 Jul; 49(13):3529-34. PubMed ID: 2499419
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo antitumorigenic activity of a mixture of lysine, proline, ascorbic acid, and green tea extract on human breast cancer lines MDA-MB-231 and MCF-7.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Med Oncol; 2005; 22(2):129-38. PubMed ID: 15965275
[TBL] [Abstract][Full Text] [Related]
27. Ornithine decarboxylase over-expression stimulates mitogen-activated protein kinase and anchorage-independent growth of human breast epithelial cells.
Manni A; Wechter R; Gilmour S; Verderame MF; Mauger D; Demers LM
Int J Cancer; 1997 Jan; 70(2):175-82. PubMed ID: 9009157
[TBL] [Abstract][Full Text] [Related]
28. Biological activity of the S-adenosylmethionine decarboxylase inhibitor SAM486A in human breast cancer cells in vitro and in vivo.
Hu X; Washington S; Verderame MF; Demers LM; Mauger D; Manni A
Int J Oncol; 2004 Dec; 25(6):1831-8. PubMed ID: 15547724
[TBL] [Abstract][Full Text] [Related]
29. Activation of caspase-3 activity and apoptosis in MDA-MB-468 cells by N(omega)-hydroxy-L-arginine, an inhibitor of arginase, is not solely dependent on reduction in intracellular polyamines.
Singh R; Pervin S; Wu G; Chaudhuri G
Carcinogenesis; 2001 Nov; 22(11):1863-9. PubMed ID: 11698350
[TBL] [Abstract][Full Text] [Related]
30. Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines.
Morris VL; Tuck AB; Wilson SM; Percy D; Chambers AF
Clin Exp Metastasis; 1993 Jan; 11(1):103-12. PubMed ID: 8422701
[TBL] [Abstract][Full Text] [Related]
31. AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport.
Samal K; Zhao P; Kendzicky A; Yco LP; McClung H; Gerner E; Burns M; Bachmann AS; Sholler G
Int J Cancer; 2013 Sep; 133(6):1323-33. PubMed ID: 23457004
[TBL] [Abstract][Full Text] [Related]
32. Influence of gastrin, gastrin receptor blockers, epidermal growth factor, and difluoromethylornithine on the growth and the activity of ornithine decarboxylase of colonic carcinoma cells.
Eggstein S; Imdahl A; Kohler M; Waibel M; Farthmann EH
J Cancer Res Clin Oncol; 1991; 117(1):37-42. PubMed ID: 1997467
[TBL] [Abstract][Full Text] [Related]
33. Hyperglycemic conditions proliferate triple negative breast cancer cells: role of ornithine decarboxylase.
Capellen CC; Ortega-Rodas J; Morwitzer MJ; Tofilau HMN; Dunworth M; Casero RA; Chandra S
Breast Cancer Res Treat; 2021 Nov; 190(2):255-264. PubMed ID: 34529197
[TBL] [Abstract][Full Text] [Related]
34. The effect of tumor burden on ornithine decarboxylase activity in mice.
Saydjari R; Alexander RW; Upp JR; Poston GJ; Barranco SC; Townsend CM; Thompson JC
Cancer Invest; 1991; 9(4):415-9. PubMed ID: 1884248
[TBL] [Abstract][Full Text] [Related]
35. Antimetastatic activity of DL-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, in mice.
Sunkara PS; Rosenberger AL
Cancer Res; 1987 Feb; 47(4):933-5. PubMed ID: 3100031
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment of lupus nephritis in MRL-lpr/lpr mice by inhibiting ornithine decarboxylase.
Gunnia UB; Amenta PS; Seibold JR; Thomas TJ
Kidney Int; 1991 May; 39(5):882-90. PubMed ID: 2067204
[TBL] [Abstract][Full Text] [Related]
37. Polyamines in cultured rabbit corneal cells.
Du H; Viar MJ; Johnson LR; Watsky MA
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2512-7. PubMed ID: 12766050
[TBL] [Abstract][Full Text] [Related]
38. 2-Deoxy-D-glucose inhibits the antitumor effects of alpha-difluoromethylornithine on the growth of colon cancer in vivo.
Saydjari R; Upp JR; Alexander RW; Barranco SC; Townsend CM; Thompson JC
Invest New Drugs; 1989 Jul; 7(2-3):131-8. PubMed ID: 2507471
[TBL] [Abstract][Full Text] [Related]
39. Differential sensitivity of various human tumors to inhibition of polyamine biosynthesis in vivo.
Saydjari R; Alexander RW; Upp JR; Barranco SC; Townsend CM; Thompson JC
Int J Cancer; 1991 Jan; 47(1):44-8. PubMed ID: 1985877
[TBL] [Abstract][Full Text] [Related]
40. A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest.
Howlett AR; Petersen OW; Steeg PS; Bissell MJ
J Natl Cancer Inst; 1994 Dec; 86(24):1838-44. PubMed ID: 7990158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
